Cognition Therapeutics Has Received A Notice Of Allowance For Its U.S. Patent Application 16/783,943 Titled “Isoindoline Compositions And Methods For Treating Neurodegenerative Disease (Including Alzheimer’s Disease)”.
https://patentcenter.uspto.gov/#!/applications/16783943/ifw/docs